A better way to invest in startups.
For Mr. Lasher, the question of how to invest in Israel was answered by Jon Medved, the founder of OurCrowd, which enables people to invest in Israeli companies before those companies go public on the stock exchange.
Read more on Jewish Standard here.
Morphisec, the leader in Moving Target Defense-based cybersecurity, today announced that Morphisec Endpoint Threat Prevention Solution blocked 100 percent of exploits and evasive malware in SE Labs’ Advanced Endpoint Protection Test.
Read more on PR Newswire here.
The Sweetch app, now in clinical trials at Johns Hopkins Medical Center in Maryland, predicts personal diabetes risk and encourages long-term behavioral change to prevent diabetes.
Read more on Israel21c here.
From a security perspective, the ultimate user experience involves both fraud protection and enabling legitimate users as unobtrusively as possible, BioCatch vice president Frances Zelazny said.
Read more on Bankless Times here.
Iron Dome developer nabs investment from New Zealand
See OurCrowd’s Andy Kaye on i24 News here.
Innoviz Technologies, a leading provider of LiDAR sensing solutions, announced today that is has won the CES 2018 Innovation Awards Honoree recognition in the Vehicle Intelligence and Self-Driving Technology category for its groundbreaking InnovizPro™ High Definition Solid State LiDAR.
Read more on PR Newswire here.
Based in Petah Tikva, DreaMed has two products: Advisor decision-support technology to optimize and fine-tune patient-specific insulin treatment plans (FDA and CE approval pending); and Glucositter, the first artificial pancreas system to receive the CE Mark for sales in Europe.
Read more on Israel21c here.
OurCrowd, one of the largest equity crowdfunding platforms in the world, has invested in Nexa3D maker of ultra-fast Stereolithography professional-grade 3D printers.
Read more on Crowdfund Insider here.
![[CEO Jon Medved in Jewish Standard] Israel’s angels in America](https://blog.ourcrowd.com/wp-content/uploads/2017/11/Jewish-Standard-NEW.jpg)
![[Morphisec in PR Newswire] Morphisec Demonstrates Superior Prevention Capabilities in the Lab and Field](https://blog.ourcrowd.com/wp-content/uploads/2017/09/PR_newswire.jpg)
![[Sweetch in Israel21c] 10 advances helping diabetics prevent and manage their illness](https://blog.ourcrowd.com/wp-content/uploads/2017/10/israel-21cNEW-1.jpg)
![[BioCatch in Bankless Times] BioCatch and the process of continuous authentication](https://blog.ourcrowd.com/wp-content/uploads/2017/11/Bankless-Times-NEW.jpg)
![[OurCrowd on i24 News] Iron Dome developer nabs investment from New Zealand](https://blog.ourcrowd.com/wp-content/uploads/2017/11/i24-news-NEW.jpg)
![[OurCrowd in Crowdfund Insider] OurCrowd Backs Nexa3D, Maker of Professional Grade 3D Printers](https://blog.ourcrowd.com/wp-content/uploads/2017/10/Crowdfund-Insider-NEW.jpg)